Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections
October 05, 2023 09:00 ET
|
Exbaq LLC
Vaccine Stimulates the Body’s Macrophages, Engulfing and Killing Gram Positive/Negative Bacteria, and FungiVaccine provides protection against infections within 24hours and protection lasts for up to...
Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors
February 14, 2023 07:30 ET
|
Selux Diagnostics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that...
FDA Clears 'Selux NGP System' for Rapid Antibiotic Susceptibility Testing
January 19, 2023 07:00 ET
|
Selux Diagnostics
BOSTON, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced it has received...
Ondine Biomedical to Present Nasal Photodisinfection at the 5th International Conference on Prevention & Infection Control (ICPIC 2019)
September 09, 2019 08:00 ET
|
Ondine Biomedical Inc.
Vancouver, Canada, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Ondine announces that Dr. Nicolas Loebel will address the 5th International Conference on Prevention & Infection Control (ICPIC) held in...
Ondine Biomedical Inc. to Present Candida auris Program Results at the 5th International Conference on Prevention & Infection Control (ICPIC, 2019, Geneva)
September 06, 2019 11:37 ET
|
Ondine Biomedical Inc.
Vancouver, Canada, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announces presentation of data demonstrating high levels of efficacy of its Photodisinfection program against Candida...
Ondine Biomedical’s Nasal Photodisinfection is Selected as a Top Innovation of the Year
July 29, 2019 08:00 ET
|
Ondine Biomedical Inc.
Vancouver, Canada, July 29, 2019 (GLOBE NEWSWIRE) -- The Infection Prevention Strategy (TIPS) today announced Ondine Biomedical Inc.’s nasal Photodisinfection among the winners of the TIPS Top...
Ondine Biomedical Introduces Nasal Photodisinfection to Quebec through MAM Medical Inc.
April 29, 2019 06:00 ET
|
Ondine Biomedical Inc.
Vancouver, BC, Canada, April 29, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announced today it has entered into an exclusive agency agreement with MAM Medical Inc. to represent Ondine’s...
Multidrug-Resistant Candida auris and Aspergillus fumigatus Eradicated by Ondine Biomedical’s antimicrobial Photodisinfection
April 10, 2019 16:25 ET
|
Ondine Biomedical Inc.
Vancouver, BC Canada, April 10, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announced today that its antimicrobial Photodisinfection Therapy (aPDT) successfully eradicated in laboratory testing...
Global charity discovers superbugs in pork products
December 19, 2018 08:00 ET
|
World Animal Protection
Toronto, ON, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Bacteria that is resistant to antibiotics most critically important to humans, has been found in pork from supermarket shelves in Brazil, Spain and...
Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets
September 06, 2018 07:00 ET
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ’Company’)Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets Discovery Enabled by Discuva Platform and...